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Measles is one of the most infectious human viruses and a significant 
cause of childhood mortality. Population immunity of around 95% 
is necessary to prevent ongoing virus transmission.[1] Significant 
advances have been made towards measles elimination through 
a cost-effective vaccine. The World Health Organization (WHO) 
strategy for reducing measles mortality[2] has been implemented by 
most WHO member states, including South Africa since 1996. This 
consists of four arms: (i) achieving sustained high routine first-dose 
vaccination coverage to infants; (ii) providing a second opportunity 
for measles vaccination for all children through routine services 
or mass campaigns; (iii) surveillance of measles and vaccination 
coverage; and (iv) improving management of complicated cases. The 
South African childhood schedule recommends routine measles 
vaccination at 9 months and 18 months of age.
Non-selective mass vaccination campaigns (MVCs) that vaccinate 
all children in a specified target age group regardless of prior 
vaccination status have increased coverage, particularly in developing 
countries where routine health services are weak.[3] MVCs reach 
children who were not reached by routine programmes,[4] provide 
a second opportunity for those who did not initially seroconvert, 
and increase population immunity rapidly, potentially interrupting 
ongoing transmission.[3] The worldwide impact of MVCs on the 
incidence of measles has been documented,[1] and revised WHO 
policy includes MVCs as an outbreak response activity.[2] 
Despite considerable progress towards measles elimination, 
epidemics have recently occurred in 28 sub-Saharan African 
countries, including South Africa. In 2009/2010 approximately 
200 000 cases were reported in sub-Saharan Africa,[5] of which over 
18 000 confirmed cases were in South Africa.[6] The underlying cause 
of these outbreaks is primarily insufficient coverage, but also logistics, 
including cold-chain maintenance.[5] 
The South African epidemic started in the Gauteng province in 
March 2009 and, despite targeted campaigns from May to October 
2009[7] in affected areas, spread to the rest of the country. An MVC 
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Background. Despite significant advances in measles control, large epidemics occurred in many African countries in 2009 - 2011, including 
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nationally in April 2010 and coincided with the epidemic.
Aim. A community survey was conducted in the Western Cape to assess measles vaccination coverage attained by routine and campaign 
services, in children aged 6 to 59 months at the time of the mass campaign, from high-incidence areas. 
Methods. Households were consecutively sampled in high-incidence areas identified using measles epidemic surveillance data. A caregiver 
history of campaign vaccination and routine vaccination status from the child’s Road to Health card were collected. Pre- and post-campaign 
immunity was estimated by analytical methods.
Results. Of 8 332 households visited, there was no response at 3 435 (41.2%); 95.1% (1 711/1 800) of eligible households participated; and 
91.2% (1 448/1 587; 95% confidence interval 86 - 94%) of children received a campaign vaccination. Before the campaign, 33.0% (103/312) 
of 9 - 17-month-olds had not received a measles vaccination, and this was reduced to 4.5% (14/312) after the campaign. Of the 1 587 
children, 61.5% were estimated to have measles immunity before the campaign, and this increased to 94.0% after the campaign. 
Discussion. Routine services had failed to achieve adequate herd immunity in areas with suspected highly mobile populations. Mass 
campaigns in such areas in the Western Cape significantly increased coverage. Extra vigilance is required to monitor and sustain adequate 
coverage in these areas.
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against measles and polio had been planned; however, as a result 
of the epidemic the targeted age group for measles vaccination was 
extended from 9 to 59 months, to include children from 6 months 
to 15 years. This was conducted nationally from 12 to 23 April 2010.
Over 2 000 cases[6] were confirmed in the 5.5 million[8] people 
residing in the Western Cape province; 85% occurred in the 
Metropole district, which houses 65% of the population. Confirmed 
cases were underestimated, as laboratory confirmation was halted 
at the peak of the epidemic (Department of Health, Provincial 
Government of the Western Cape – routine surveillance data, 2010, 
unpublished). The Western Cape epidemic started in October 2009 
and peaked in March 2010. Over 60% of patients were under 5 years 
of age and 29% were in the 6 - 11-month age group. Of patients 
in the Metropole district 96% had not received a dose of measles 
vaccine or had unknown vaccination status, and the case-fatality 
ratio in under-5s was 6.9/1 000 (Department of Health, Provincial 
Government of the Western Cape – routine surveillance data, 2010, 
unpublished). 
Routine administrative monitoring of vaccination coverage is 
required in all health districts in the country. The mobility of people 
in South Africa means that official district population denominators, 
especially in urban areas, tend to be underestimated and the large 
number of indicators considered essential by the various health 
programmes undermines accurate counts of vaccinations given. This 
leads to official coverage figures being overestimated, especially in 
areas with high population mobility. The Western Cape reported that 
measles coverage in children <1 year of age was 102.8%, 99.7% and 
102.8% for the years 2007 - 2009.[9] The potential for an outbreak was 
therefore not anticipated. In line with WHO recommendations the 
Western Cape Department of Health commissioned a community 
survey in 2010 after the MVC to monitor routine and campaign 
coverage.[10] The aim was to assess the MVC effectiveness, particularly 
in reaching children aged 6 months - 5 years at the time of the 
campaign, from communities in which the incidence of measles 
had been high, and to determine predictors of routine vaccination 
coverage and measles. 
Methods
A cross-sectional design was used and five high-incidence suburbs 
were purposively selected using provincial surveillance of measles 
cases. Each suburb includes large sections of informal housing. 
Field-mapping was conducted within each suburb to identify high-
incidence areas. All households within the high-incidence areas 
were consecutively visited and requested to participate in the survey. 
Within each household one caregiver-child pair was randomly 
selected. Households where there was no response were not revisited 
owing to the limited time available. A sample of 246 households per 
suburb was considered to provide vaccination coverage estimates 
with an alpha error of 0.05 and an absolute precision of 0.05, based 
on a coverage estimate of 80%. A caregiver-child pair was eligible to 
participate if the child was aged 9 - 62 months (equivalent to 6 - 59 
months at the time of the campaign), and had lived in the Western 
Cape for 6 months or more.
Caregivers were interviewed using a pre-piloted questionnaire, 
adapted from a previous coverage survey,[11] and routine vaccination 
status was documented from the child’s Road to Health clinic card 
(RTHC). Campaign vaccination status was not documented on 
the child’s RTHC, and caregiver history was relied upon. Local 
community members were recruited and paid a stipend to accompany 
fieldworkers in order to facilitate safer access to the communities. 
Fieldworkers consisted of three groups of undergraduate medical 
students and one group of hired fieldworkers. Fieldwork was 
conducted from 20 July to 30 August 2010.
Data analysis was done using Stata v11. Routine vaccinations 
administered during or after the MVC were not included in the 
analysis, in order to provide a pre- and post-campaign profile. 
Children without an RTHC were regarded as ‘not vaccinated’, 
because routine vaccination status according to caregiver history 
was considered unreliable. Homogeneity within high-incidence 
areas was not taken into account, as the study did not aim to 
obtain an overall estimate for the area. Prevalence estimates 
were calculated with 95% confidence intervals (CIs). Associations 
between independent categorical variables and outcomes were 
explored using a chi-square test and logistic regression. Timeliness 
of vaccination was illustrated using a cumulative time-to-event 
distribution. To facilitate comparability across suburbs for the 
number of reported barriers to access, this variable was adjusted for 
sample size per suburb.
Population immunity before and after the MVC was modelled 
based on estimates of waning maternal antibody protection for 
unvaccinated children aged 6 - 9 months,[12] immunity following 
routine and campaign vaccine dose(s),[13] and immunity following 
measles infection (assumed complete). The effect of parameter 
uncertainty on the model estimates was assessed through probabilistic 
sensitivity analysis in which all parameters were varied simultaneously 
within the published confidence bounds in a Monte Carlo simulation 
(1 000 runs). Full details of the model and sensitivity analysis are 
available from the corresponding author.
Verbal informed consent was obtained from all participant 
caregivers. The Declaration of Helsinki[14] and the South African 
Medical Research Council guidelines on ethics for medical research[15] 
were followed. Ethics approval was obtained from the University of 
Cape Town’s Human Research Ethics Committee (HREC Ref.: 
331/2010).
Up to date for age was defined as: children aged 9 - 17 months 
who had at least one routine measles vaccination and children 18 
months and older who had at least two routine measles vaccinations 
according to the RTHC.
Results
The survey was conducted in Site B Khayelitsha, Philippi, Mbekweni, 
Delft and Du Noon. Of the 8 332 households visited, there was no 
response at 3 435 (41.2%): 95.1% (1 711 out of 1 800) of eligible 
households participated. A total of 1 587 completed questionnaires 
were analysed (Fig. 1). 
Of primary caregivers, 96.5% were women, with a median age of 29 
years (range 15 - 86 years), and 93.3% reported that they were literate. 
The mean age of the children at the time of the campaign was 2.5 years 
(95% CI 2.4 - 2.5) (Table 1). Caregivers reported that 8.9% (142/1 587) 
of children had had measles (Table 1), and 89.8% (106/118) reported 
that it occurred between December 2009 and July 2010, with a peak 
in April 2010; 79.7% (94/118) of cases had occurred before the MVC, 
with a sharp decline in the incidence rate after the MVC. 
Of the caregivers 75.2% (1 194/1 587) had an RTHC for their child, 
21.5% (341) reported that the RTHC was elsewhere and 3.3% (52) 
were not in possession of an RTHC. Caregivers in Delft (82.3%) and 
Du Noon (85.1%) were significantly more likely to have a card than 
those in the other sites (Table 1). Of caregivers without an RTHC, 
55.0% (216/393) did not know how many doses of measles vaccine 
had been administered to their child. 
Of children older than 9 months with an RTHC, 79.6% (862/1 083) 
were up to date for age for measles vaccination. Significant variability 
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existed across study sites (Fig. 2). Of all children, 59.5% (with 
and without an RTHC) aged 9 months and older before the mass 
campaign were up to date for age. Significantly more children in 
the age group 9 - 17 months were up to date for age compared 
with children aged >18 months (RTHC subgroup: 85.7% (95% CI 
80.6 - 89.8) and 77.8% (95% CI 74.9 - 80.6%), respectively). Routine 
vaccination status was not significantly associated with age and 
literacy of the primary caregiver, caregiver perceptions of clinic staff, 
or age and gender of the child.
Date of vaccination was documented for 68.1% (987/1 449) of those 
eligible for the first measles dose and 57.4% (653/1 137) of those eligible 
for the second measles dose. The median time from the due date to 
vaccination was 8 days (interquartile range (IQR) 1 - 29) for measles 1, 
and 20 days (IQR 1 - 78) for measles 2. Fig. 3 illustrates the cumulative 
percentage of children given the first and second measles vaccinations, 
demonstrating delays in the administration of the second dose.
After adjusting for age, documented routine vaccination coverage 
before the mass campaign was significantly associated with absence 
Table 1. Demographic and measles-related history of study participants
Overall Mbekweni Site B Philippi Delft Du Noon
Gender of child, % female 52.4 47.0 56.0 52.7 54.4 51.4
(95% CI) (49.9 - 54.9) (41.4 - 52.4) (50.8 - 61.4) (46.2 - 58.6) (49.3 - 59.6) (45.2 - 58.0)
Age of child (years), mean at time of campaign 2.5 2.6 2.6 2.4 2.4 2.4
(95% CI) (2.4 - 2.5) (2.5 - 2.7) (2.4 - 2.7) (2.2 - 2.5) (2.3 - 2.5) (2.2 - 2.5)
Gender of primary caregiver, % female 96.5 97.3 96.6 97.3 93.5 98.8
(95% CI) (95.5 - 97.4) (94.9 - 98.8) (94.1 - 98.2) (94.6 - 98.9) (90.6 - 95.8) (96.5 - 99.7)
Age of primary caregiver (years), median 29 30 30 29 29 28
(range) (15 - 86) (15 - 70) (17 - 71) (15 - 69) (16 - 70) (17 - 86)
Basic literacy of primary caregiver, % 93.3 90.0 94.6 96.2 94.5 91.0
(95% CI) (91.9 - 94.4) (86.0 - 92.8) (91.7 - 96.7) (93.1 - 98.2) (91.5 - 96.4) (86.7 - 94.3)
History of measles, % (n) 9.0 (142) 6.0 (20) 12.6 (44) 10.7 (28) 7.4 (28) 8.9 (22)
(95% CI) (7.6 - 10.5) (3.7 - 9.1) (9.2 - 16.4) (7.2 - 15.0) (4.8 - 10.2) (5.6 - 13.1)
History of campaign dose received, % (n) 91.2 (1 448) 93.4 (311) 92.0 (324) 90.1 (237) 90.0 (351) 90.4 (225)
(95% CI) (89.7 - 92.6) (90.2 - 95.8) (88.7 - 94.6) (85.9 - 93.4) (86.6 - 92.8) (86.0 - 93.7)
RTHC seen, % (n) 75.2 (1 194) 70.0 (233) 71.9 (253) 66.5 (175) 82.3 (321) 85.1 (212)
(95% CI) (73.0 - 77.3) (64.7 - 74.8) (66.9 - 76.5) (60.5 - 72.2) (78.2 - 86.0) (80.1 - 89.3)
1 
Households visited: 8 332
Participated in survey: 1 711
(20% of households visited)
Completed valid questionnaires: 1587
(19% of households visited)
Absent: 3 435 (41.2%)
Not eligible: 3 097 (37.2%)
Refused: 89 (1.1%) 
Excluded:
Date of birth missing: 93 (5.4%)
Invalid dates recorded: 31 (1.8%) 
Mbekweni:
333
21.0%
Site B:
352
22.2%
Philippi:
263
16.6%
Delft:
390
24.6%
Du Noon:
249
15.7%
Fig. 1. Selection of study participants. 
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of a history of measles disease in children aged 9 months and older. 
One measles vaccination was associated with a 49% reduced odds 
of contracting measles compared with no measles vaccination 
(p=0.003), and two measles vaccinations were associated with a 61% 
reduced odds of contracting measles compared with no measles 
vaccination (p<0.001). Two measles vaccinations were associated 
with a 46% reduced odds of contracting measles compared with one 
measles vaccination (p=0.009). 
Of caregivers who responded to questions relating to the health 
services, 85.0% (1 238/1 456) reported that the clinic immunisation 
staff had a positive attitude towards them and their child, 8.2% 
(n=118) reported a negative attitude, and 6.9% (n=100) were neutral. 
The commonest categories of reasons reported for caregivers 
not accessing routine vaccination services were related to lack of 
information (n=124), followed by personal obstacles (n=99) and 
clinic-related factors (n=80). Lack of information included reasons 
such as ‘unaware of need to return’ (n=41), ‘unaware of need for 
vaccination’ (n=30) and ‘not in area at time when vaccination due 
and unaware that child can go to any clinic for vaccination’ (n=25). 
Reported personal obstacles included reasons such as ‘primary 
caregiver too busy’ (n=44), ‘family problem’ (n=21) and migration-
related reasons (n=19). 
Eﬀ ectiveness of the mass vaccination campaign
Caregivers reported that 91.2% of children (1 448/ 1 587) received 
a dose of measles vaccine during the MVC. Before the MVC, 33.0% 
and 30.1% of children aged 9 - 17 months and 18 months and older, 
respectively, had not had a dose of measles vaccine, whereas after the 
MVC this was significantly reduced to 4.5% and 2.3%, respectively 
(Table 2).
Immunity from vaccinations administered before the campaign 
was estimated at 81.6% for those with an RTHC, and increased to 
95.8% after the campaign. For all children (with and without an 
RTHC), estimated immunity from vaccination was 61.5% before 
and 94.0% after the mass campaign. The outbreak of measles alone 
increased immunity by 3.6% and 5.2% for those with an RTHC and 
all children, respectively (Fig. 4).
Discussion
Routine vaccination services fail to achieve adequate herd immunity 
in high-risk areas. Caregivers identified lack of information and 
personal obstacles as the commonest barriers. This finding differs 
from the 2005 Western Cape provincial vaccination survey,[11] where 
clinic factors (47% of respondents) followed by lack of information 
(27% of respondents) were most frequent. High-risk populations 
have special access-related needs, and those involved in routine 
services and mass campaigns need to facilitate access for high-
risk populations by more effectively informing communities, and 
particularly caregivers moving into the area. Community health 
workers linked to primary care services are suitably placed to 
facilitate access to health services by monitoring vaccination (and 
nutrition) status and helping caregivers make sense of the RTHC.
Vaccinations documented on the RTHC were generally 
administered on time, the second dose less so than the first. Timely 
vaccination ensures that children are not at risk at an early age. Each 
time children attend health services represents a chance to vaccinate 
Table 2. Proportion of children unvaccinated before and after the MVC, stratified by age group
9 - 17 months old,
card only (N=244)
9 - 17 months old,
card plus history (N=312)
18 months and older, 
card only (N=839)
18 months and older, 
card plus history (N=1 137)
Portion Before After Before After Before After Before After
With zero doses, % (n) 14.3 (35) 1 (3) 33.0 (103) 4.5 (14) 5.2 (44) <1 (2) 30.1 (342) 2.3 (26)
(95% CI) (10 - 19) (0.2 - 4.0) (28 - 39) (2 - 7) (4 - 7) (<0.01 - 0.80) (2.7 - 3.3) (1.5 - 3.3)
% change - 91% reduction - 86% reduction - 95% reduction - 92% reduction
Fig. 4. Estimated measles immunity of participant children. Error bars 
represent 95% confi dence intervals estimated by Monte-Carlo simulation.
Fig. 2. Proportion of children up to date for age before the MVC, stratifi ed by 
suburb. Error bars represent 95% confi dence intervals.
Fig. 3. Timeliness of fi rst and second measles vaccinations in children with 
date of vaccination documented on the RTHC.
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them, but the opportunity is often missed. Routine checking of 
children’s RTHCs at every visit, and provision of vaccinations at all 
health facilities and after-hours, are therefore required.
MVCs can rapidly increase vaccination coverage in high-risk 
populations, as evidenced by the increase in coverage and the 
decline in measles incidence after the MVC. Data showed that the 
outbreak would have continued had it not been for the MVC, as 
herd immunity would still have been below the required threshold. 
Earlier implementation of the MVC would have had a greater 
impact. This is supported by a systematic review by Cairns et al.16 
that demonstrated a decrease in morbidity associated with rapid 
outbreak response vaccination.
MVCs have been criticised because they are expensive, logistically 
challenging and resource intensive. Human resources are usually 
drawn from routine primary care services, resulting in their 
interruption and a temporary increase in workload.17 However, these 
campaigns are a necessary intervention, proven to decrease measles 
morbidity and mortality.18 The negative impact on health services 
can be mitigated by careful planning and conducting the MVC over 
as few days as is feasible. Campaigns have also had positive spill-over 
effects on health systems and routine immunisation services, by 
providing opportunities for better collaboration, improved knowledge 
of vaccination, micro-planning, data quality and surveillance, and 
increased community demand for vaccinations.19 
Vaccination status as documented on RTHCs is often used as 
a proxy indicator of population immunity. Tools are lacking to 
interpret outbreak potential in the light of survey data. A risk 
assessment tool should be developed to model survey data against 
immunological assays to estimate levels of neutralising antibodies. 
We estimated population immunity using crude assumptions, and 
the methodology requires validation and refinement. The absence 
of recent data describing the decay of maternal antibodies, and the 
impact of HIV status (maternal and infant), gestational age and 
maternal measles incidence on the level and attrition of maternally 
acquired immunity, limit these assumptions. Additionally, the effect 
of HIV status and vaccination practices on vaccine effectiveness was 
not taken into account.
The surveillance data from the Western Cape epidemic showed a 
higher incidence of measles in areas with large informal settlements, 
consistent with data on other outbreaks. Population density 
combined with an influx of susceptible persons and decreased 
access to healthcare services synergistically increase the risk.20 
Residential mobility is highly prevalent in informal settlements,21 
is a determinant of non-availability of RTHCs,21 and acts as an 
access barrier to healthcare. Sustainability of the impact of MVCs 
in informal settlements may be limited. A national MVC evaluation 
in Khayelitsha found a precipitous drop in vaccination status of 
immigrants to pre-campaign levels 6 months after an MVC.22
Large coverage surveys at a provincial or district level fail to 
identify specific high-risk areas with low coverage. Administrative 
coverage estimates are also poor and do not account for in-migration 
in rapidly expanding areas. Lot quality sampling may be used to 
identify these high-risk areas, and periodic surveys and mop-up 
vaccination campaigns should be conducted. In keeping with 
the vision of the National Department of Health to revitalise 
primary healthcare, community health workers are ideally placed 
to strengthen immunisation services and could monitor coverage in 
high-risk areas and facilitate access to routine services.
Limitations
A notable limitation of this study was non-response (41.2%). 
Children attending crèches were also not included. Those who 
had resided in the Western Cape for less than 6 months were also 
considered ineligible, as the study assessed the effectiveness of the 
campaign in reaching those resident at the time of the campaign. 
Coverage estimates may be overestimated if those selected were 
more likely to be vaccinated than those who were absent. Areas that 
were known to be volatile were avoided, and it is likely that their 
coverage is lower than elsewhere. Vaccination by the MVC is likely to 
have been overestimated owing to recall and social desirability bias. 
Caregiver knowledge regarding the vaccination schedule was limited, 
and routine coverage in the whole study population was therefore 
underestimated as children without an RTHC were classified as 
unvaccinated. Socio-economic and mobility data were not collected, 
which represents a limitation.
Recommendations
A proactive approach is required to prevent future measles outbreaks. 
Although a sensitive surveillance system is in place to identify 
outbreaks, one case of measles must be considered to be an epidemic 
and a rapid response should be initiated. Routine services should 
monitor coverage in high-risk areas such as informal settlements by 
conducting regular surveys, and immediate action must be taken in 
areas where coverage fails to achieve herd immunity. Community 
health workers and school nurses are suitably placed in the primary 
healthcare re-engineering to monitor and promote the uptake of 
vaccination. All health facilities should contribute by ensuring that no 
opportunity for vaccination is missed. MVCs are an important strategy 
in controlling measles, and careful planning is required to ensure 
that these are used as opportunities for health systems strengthening. 
Targeted post-MVC surveys are useful for assessing risk and should 
routinely form part of MVC planning. Further research is required in 
developing validated rapid risk assessment methodologies.
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